Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $20,577 | 1,400 | 99.7% |
| Education | $69.67 | 8 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $2,453 | 199 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $2,263 | 153 | $0 (2024) |
| Lilly USA, LLC | $1,492 | 132 | $0 (2024) |
| ABBVIE INC. | $1,444 | 97 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $993.33 | 59 | $0 (2024) |
| GlaxoSmithKline, LLC. | $932.74 | 52 | $0 (2024) |
| PFIZER INC. | $917.32 | 76 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $893.81 | 86 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $838.79 | 39 | $0 (2024) |
| Allergan, Inc. | $537.19 | 52 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,837 | 174 | AstraZeneca Pharmaceuticals LP ($384.10) |
| 2023 | $3,097 | 177 | Bayer Healthcare Pharmaceuticals Inc. ($424.99) |
| 2022 | $2,670 | 182 | Novo Nordisk Inc ($424.86) |
| 2021 | $2,811 | 181 | AbbVie Inc. ($428.41) |
| 2020 | $2,086 | 145 | Novo Nordisk Inc ($396.13) |
| 2019 | $2,403 | 182 | AstraZeneca Pharmaceuticals LP ($340.14) |
| 2018 | $2,192 | 166 | AstraZeneca Pharmaceuticals LP ($336.33) |
| 2017 | $2,552 | 201 | AstraZeneca Pharmaceuticals LP ($369.14) |
All Payment Transactions
1,408 individual payment records from CMS Open Payments — Page 1 of 57
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Tris Pharma Inc | Dyanavel XR (Drug) | Food and Beverage | In-kind items and services | $11.28 | General |
| Category: ADHD | ||||||
| 12/19/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $20.81 | General |
| Category: RESPIRATORY | ||||||
| 12/16/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $17.27 | General |
| Category: PAIN | ||||||
| 12/10/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $23.04 | General |
| Category: DIABETES | ||||||
| 12/03/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $12.62 | General |
| Category: Obesity | ||||||
| 12/02/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $16.50 | General |
| Category: Respiratory | ||||||
| 11/25/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $17.70 | General |
| Category: Oncology | ||||||
| 11/22/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $26.99 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 11/21/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $26.59 | General |
| Category: Cardio-renal | ||||||
| 11/21/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: Diabetes Care | ||||||
| 11/20/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $21.44 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 11/19/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $16.12 | General |
| Category: PAIN | ||||||
| 11/13/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.75 | General |
| Category: Respiratory | ||||||
| 11/05/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $21.57 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/04/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $17.27 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/01/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $17.27 | General |
| Category: PAIN | ||||||
| 10/31/2024 | Tris Pharma Inc | Dyanavel XR (Drug) | Food and Beverage | In-kind items and services | $16.01 | General |
| Category: ADHD | ||||||
| 10/29/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $12.45 | General |
| Category: Obesity | ||||||
| 10/25/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.14 | General |
| Category: NEUROSCIENCE | ||||||
| 10/24/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $23.56 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 10/22/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $89.92 | General |
| Category: RESPIRATORY | ||||||
| 10/17/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $19.96 | General |
| Category: Cardio-renal | ||||||
| 10/16/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $16.22 | General |
| Category: Diabetes | ||||||
| 10/15/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $3.91 | General |
| Category: Diabetes | ||||||
| 10/14/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $13.63 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 430 | 922 | $241,414 | $50,683 |
| 2022 | 7 | 398 | 760 | $195,920 | $42,186 |
| 2021 | 9 | 442 | 772 | $198,431 | $44,719 |
| 2020 | 11 | 498 | 787 | $196,890 | $39,456 |
All Medicare Procedures & Services
34 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 202 | 554 | $204,980 | $40,646 | 19.8% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 57 | 57 | $12,483 | $4,090 | 32.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 60 | 60 | $3,420 | $1,732 | 50.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 28 | 32 | $8,096 | $1,690 | 20.9% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 59 | 156 | $6,240 | $1,460 | 23.4% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 11 | 14 | $2,814 | $547.82 | 19.5% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 13 | 49 | $3,381 | $517.44 | 15.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 177 | 439 | $162,430 | $32,837 | 20.2% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 46 | 48 | $10,512 | $3,274 | 31.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 39 | 46 | $11,638 | $2,797 | 24.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 49 | 51 | $2,907 | $1,388 | 47.8% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 57 | 138 | $5,520 | $1,323 | 24.0% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2022 | 11 | 13 | $2,613 | $480.45 | 18.4% |
| 81002 | Urinalysis, manual test | Office | 2022 | 19 | 25 | $300.00 | $86.16 | 28.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 192 | 428 | $158,360 | $34,251 | 21.6% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 49 | 49 | $9,251 | $3,198 | 34.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 49 | 59 | $14,927 | $3,023 | 20.3% |
| 90732 | Vaccine for pneumococcal polysaccharide for injection beneath the skin or into muscle, patient 2 years or older | Office | 2021 | 11 | 11 | $3,971 | $1,379 | 34.7% |
| 83036 | Hemoglobin a1c level | Office | 2021 | 52 | 132 | $5,280 | $1,282 | 24.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 49 | 50 | $2,850 | $787.17 | 27.6% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2021 | 13 | 14 | $2,814 | $525.59 | 18.7% |
| G0009 | Administration of pneumococcal vaccine | Office | 2021 | 14 | 14 | $798.00 | $220.70 | 27.7% |
| 81002 | Urinalysis, manual test | Office | 2021 | 13 | 15 | $180.00 | $52.20 | 29.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 162 | 344 | $127,280 | $22,494 | 17.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 71 | 99 | $25,047 | $3,775 | 15.1% |
About Dr. Mark Sexton, MD
Dr. Mark Sexton, MD is a Family Medicine healthcare provider based in Columbus, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/16/2006. The National Provider Identifier (NPI) number assigned to this provider is 1982678702.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mark Sexton, MD has received a total of $20,646 in payments from pharmaceutical and medical device companies, with $2,837 received in 2024. These payments were reported across 1,408 transactions from 64 companies. The most common payment nature is "Food and Beverage" ($20,577).
As a Medicare-enrolled provider, Sexton has provided services to 1,768 Medicare beneficiaries, totaling 3,241 services with total Medicare billing of $177,044. Data is available for 4 years (2020–2023), covering 34 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Columbus, GA
- Active Since 02/16/2006
- Last Updated 06/03/2015
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1982678702
Products in Payments
- FARXIGA (Drug) $1,519
- JARDIANCE (Drug) $931.89
- Ozempic (Drug) $914.86
- Kerendia (Drug) $838.79
- VRAYLAR (Drug) $755.98
- XARELTO (Drug) $583.75
- Saxenda (Drug) $532.01
- NURTEC ODT (Drug) $527.62
- TRULICITY (Drug) $421.45
- UBRELVY (Drug) $416.55
- TRELEGY ELLIPTA (Drug) $392.46
- MOUNJARO (Drug) $381.01
- EMGALITY (Drug) $366.73
- Rybelsus (Drug) $354.18
- Azstarys (Drug) $340.83
- NEXLETOL (Drug) $333.68
- MYRBETRIQ (Drug) $330.49
- JANUVIA (Drug) $321.76
- Aimovig (Biological) $313.79
- INVOKANA (Drug) $287.44
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Columbus
Brian Beesley, Do, DO
Family Medicine — Payments: $1.5M
Dr. Jeffrey Kingsley, D.o, D.O
Family Medicine — Payments: $407,144
Dr. Joseph Surber, Do, DO
Family Medicine — Payments: $147,174
Bantwal Baliga, Md,Dgo, MD,DGO
Family Medicine — Payments: $124,562
Bryan Feldman, D.o, D.O
Family Medicine — Payments: $48,287
Elizabeth Martin, M.d, M.D
Family Medicine — Payments: $27,168